帕瑞昔布超前鎮(zhèn)痛對膽囊切除術(shù)麻醉的影響

郭興彩++趙懷金

[摘要] 目的 對帕瑞昔布超前鎮(zhèn)痛對瑞芬太尼全憑靜脈麻醉腹腔鏡膽囊切除術(shù)的麻醉用量及術(shù)后疼痛的影響進(jìn)行分析探討。 方法 將該院2014年1—12月收治的93例患者隨機(jī)分為I組（對照組）、II組（超前鎮(zhèn)痛用藥）及III組（術(shù)后用藥鎮(zhèn)痛），每組31例患者，對比3組患者的疼痛程度、血漿P物質(zhì)（substance P）、白細(xì)胞介素6（IL-6）及不良反應(yīng)發(fā)生率。結(jié)果 3組患者術(shù)后12 h及24 h的VAS評分均明顯低于術(shù)后1 h，差異有統(tǒng)計(jì)學(xué)意義（P<0.05）。II組患者術(shù)后阿片類藥物使用率明顯少于I組及III組（P<0.05）。手術(shù)結(jié)束后及術(shù)后24 h，II組患者的IL-6水平明顯低于I組及III組（P<0.05）。3組患者手術(shù)前后的血漿P物質(zhì)濃度及不良反應(yīng)發(fā)生率差異無統(tǒng)計(jì)學(xué)意義（P>0.05）。 結(jié)論 對腹腔鏡膽囊切除術(shù)患者手術(shù)前靜脈注射帕瑞昔布進(jìn)行超前鎮(zhèn)痛能有效減少術(shù)后阿片類藥物用量，抑制患者體內(nèi)的IL-6的釋放，緩解患者疼痛，在臨床上值得推廣應(yīng)用。

[關(guān)鍵詞] 帕瑞昔布；瑞芬太尼；腹腔鏡； 膽囊切除術(shù)

[中圖分類號] R614 [文獻(xiàn)標(biāo)識碼] A [文章編號] 1674-0742（2015）09（a）-0001-03

The Effect of Preemptive Analgesia with Parecoxib on the Anesthesia of Cholecystectomy

GUO Xing-cai， ZHAO Huai-jin

Anesthesiology Department， Tengnan Hospital， Shandong Energy Zaozhuang Mining Group， Jining， Shandong Province， 277606 China

[Abstract] Objective To study the dosage of preemptive analgesia with Parecoxib and its effect on postoperative pain in patients undergoing laparoscopic cholecystectomy with total intravenenous anesthesia. Methods Ninety-three cases admitted in our hospital from January 2014 to December 2014 were randomly divided into group I （control group）， group II treated by drugs for preemptive analgesia and group III treated by drugs for postoperative analgesia with 31 cases in each. The pain degree， plasma substance P， interleukin 6（IL-6） and incidence of side effects were compared between the three groups. Results The VAS score in the 3 groups at 12 hours and 24 hours after operation were much lower than those at 1 hour after operation， P<0.05. The postoperative opioid drugs use rate was obviously lower in group II than that in group I and group III， P<0.05. The IL-6 level was much lower in group II than that in group I and group III at the end of surgery and at 24h after surgery， P<0.05. The difference in the plasma substance P between the 3 groups before and after operation was not statistically significant， P>0.05. No statistically significant difference was found in the incidence of side effects between the 3 groups， P>0.05. Conclusion For patients undergoing laparoscopic cholecystectomy， intravenous injection of Parecoxib before the surgery for preemptive analgesia can effectively reduce the dosage of opioid drugs used after surgery， inhibit the release of IL-6 and alleviate the pain， so it is worthy of clinical application and promotion.

[Key words] Parecoxib； Remifentanil； Laparoscope； Cholecystotomy

麻醉可以使患者在手術(shù)過程中完全無痛，但是術(shù)后還是會出現(xiàn)疼痛困擾。雖然，術(shù)后鎮(zhèn)痛能夠?yàn)榛颊呔徑馔纯啵翘弁粗委熐闆r仍然不太理想，約有80%患者術(shù)后會出現(xiàn)不同程度的疼痛[1]。帕瑞昔布鈉是靜脈用的COX-2抑制劑，具有鎮(zhèn)痛、消炎作用，且對腸胃功能及血小板功能的影響小。臨床上關(guān)于帕瑞昔布在腹腔鏡膽囊切除術(shù)后鎮(zhèn)痛雖多篇報(bào)道，但是在超前鎮(zhèn)痛中的應(yīng)用效果還有較大爭議[2]。為了對帕瑞昔布超前鎮(zhèn)痛對腹腔鏡膽囊切除術(shù)中的應(yīng)用價(jià)值進(jìn)行分析探討，該研究對該院2014年1—12月收治的93例腹腔鏡膽囊切除術(shù)患者進(jìn)行隨機(jī)對照研究，現(xiàn)報(bào)道如下。